Orca Bio
Orca Bio is a late-stage biotechnology company, headquartered in Menlo Park, California with a cGMP manufacturing facility in Sacramento, developing high-precision allogeneic cell therapies for cancer and autoimmune diseases. Its single-cell sorting platform separates donor blood with high purity and speed to build proprietary, precisely-defined mixtures of immune and stem cells. Orca Bio's lead program TREGZI is a precision-engineered allogeneic T-cell immunotherapy for hematological malignancies, alongside investigational programs Orca-T and Orca-Q. As a clinical/therapeutics company it does not publish a public developer or API surface; this profile was surfaced as a portfolio company of Felicis and enriched with verified company identity and domain-security signals.
Orca Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Cell Therapy, Immunotherapy, and Healthcare.
Orca Bio’s developer surface includes engineering blog and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 3
The organization behind the API